Cryo-Cell International Overview
- Year Founded
-
1989
- Status
-
Public
- Employees
-
76
- Stock Symbol
-
CCEL
- Investments
-
6
- Share Price
-
$4.85
- (As of Friday Closing)
Cryo-Cell International General Information
Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
Contact Information
Website
www.cryo-cell.comCorporate Office
- 700 Brooker Creek Boulevard
- Suite 1800
- Oldsmar, FL 34677
- United States
Corporate Office
- 700 Brooker Creek Boulevard
- Suite 1800
- Oldsmar, FL 34677
- United States
Cryo-Cell International Stock Performance
As of 13-Nov-2026, Cryo-Cell International’s stock price is $4.85. Its current market cap is $39.1M with 8.06M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.85 | $5.40 | $2.72 - $5.45 | $39.1M | 8.06M | 13.7K | -$0.24 |
Cryo-Cell International Financials Summary
As of 31-Aug-2026, Cryo-Cell International has a trailing 12-month revenue of $31.1M.
|
In Thousands, USD |
TTM 31-Aug-2026 | FY 2025 30-Nov-2025 | FY 2024 30-Nov-2024 | FY 2023 30-Nov-2023 |
|---|---|---|---|---|
| EV | 39,661 | 44,013 | 79,503 | 55,612 |
| Revenue | 31,127 | 31,566 | 31,986 | 31,344 |
| EBITDA | 1,266 | 1,097 | 5,363 | (10,417) |
| Net Income | (1,945) | (2,429) | 402 | (9,522) |
| Total Assets | 62,303 | 61,729 | 64,678 | 61,221 |
| Total Debt | 8,817 | 11,559 | 12,934 | 10,896 |
Cryo-Cell International Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Cryo-Cell International Comparisons
Industry
Financing
Details
Cryo-Cell International Competitors (8)
One of Cryo-Cell International’s 8 competitors is AlphaCord, a Private Equity-Backed company based in Scottsdale, AZ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AlphaCord | Private Equity-Backed | Scottsdale, AZ | ||||
| Americord | Accelerator/Incubator Backed | New York, NY | ||||
| LifeCell (Healthcare Services) | Venture Capital-Backed | Chennai, India | ||||
| Insception Lifebank | Formerly PE-Backed | Mississauga, Canada | ||||
| Viacord | Corporate Backed or Acquired | Waltham, MA |
Cryo-Cell International Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cryo-Cell International Patents
Cryo-Cell International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2013025189-A1 | Methods for co-culturing cord blood cells or cord tissue cells with menstrual multipotent cells | Inactive | 12-Aug-2011 | ||
| CA-2795248-A1 | Cell therapy to improve wound healing and related compositions and methods | Inactive | 01-Apr-2010 | ||
| EP-2553089-A1 | Cell therapy to improve wound healing and related compositions and methods | Inactive | 01-Apr-2010 | ||
| EP-2553089-A4 | Cell therapy to improve wound healing and related compositions and methods | Inactive | 01-Apr-2010 | ||
| WO-2011123779-A1 | Cell therapy to improve wound healing and related compositions and methods | Inactive | 01-Apr-2010 | A61K35/48 |
Cryo-Cell International Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cryo-Cell International Investments & Acquisitions (6)
Cryo-Cell International’s most recent deal was a Corporate Asset Purchase with Cryo-Cell International (8,326 Square-Foot Facility in Durham, North Carolina). The deal was made on 20-Aug-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cryo-Cell International (8,326 Square-Foot Facility in Durham, North Carolina) | 20-Aug-2021 | Corporate Asset Purchase | Buildings and Property | ||
| CORD:USE Cord Blood Bank | 11-Jun-2018 | Merger/Acquisition | Other Healthcare Services | ||
| CytoMedical Design (Prepacyte-CB Cord Blood Business) | 30-Jun-2015 | Merger/Acquisition | Biotechnology | ||
| CBA Florida | 10-Mar-2015 | PIPE | Biotechnology | ||
| S-Evans Biosciences | 12-Aug-2009 | Merger/Acquisition | Biotechnology |
Cryo-Cell International ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
36.93 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Facilities
Subindustry
of 117
Rank
Percentile
Cryo-Cell International Exits (1)
Cryo-Cell International’s most recent exit was on 10-Mar-2015 from CBA Florida. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| CBA Florida | 10-Mar-2015 | Completed |
|
Cryo-Cell International Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Throne Biotechnologies | Jinan, China | 2011 | |
| S-Evans Biosciences | Hangzhou, China | 2009 | |
| CORD:USE Cord Blood Bank | Orlando, FL | 2004 |
Cryo-Cell International FAQs
-
When was Cryo-Cell International founded?
Cryo-Cell International was founded in 1989.
-
Where is Cryo-Cell International headquartered?
Cryo-Cell International is headquartered in Oldsmar, FL.
-
What is the size of Cryo-Cell International?
Cryo-Cell International has 76 total employees.
-
What industry is Cryo-Cell International in?
Cryo-Cell International’s primary industry is Other Healthcare Services.
-
Is Cryo-Cell International a private or public company?
Cryo-Cell International is a Public company.
-
What is Cryo-Cell International’s stock symbol?
The ticker symbol for Cryo-Cell International is CCEL.
-
What is the current stock price of Cryo-Cell International?
As of 13-Nov-2026 the stock price of Cryo-Cell International is $4.85.
-
What is the current market cap of Cryo-Cell International?
The current market capitalization of Cryo-Cell International is $39.1M.
-
What is Cryo-Cell International’s current revenue?
The trailing twelve month revenue for Cryo-Cell International is $31.1M.
-
Who are Cryo-Cell International’s competitors?
AlphaCord, Americord, LifeCell (Healthcare Services), Insception Lifebank, and Viacord are some of the 8 competitors of Cryo-Cell International.
-
What is Cryo-Cell International’s annual earnings per share (EPS)?
Cryo-Cell International’s EPS for 12 months was -$0.24.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
